CARIS CONFIRM

Providing medical analysis and detection of tumor-derived genetic variants and minimal residual disease in circulating tumor DNA (ctDNA) for scientific and medical research purposes

Medical testing for diagnostic or treatment purposes in the field of oncology, namely, detection of tumor-derived genetic variants and minimal residual disease in circulating tumor DNA (ctDNA)